Fresenius Medical Care and Aetna Collaborate to Provide Coordinated Care Management for End Stage Renal Disease Patients

  Fresenius Medical Care and Aetna Collaborate to Provide Coordinated Care
  Management for End Stage Renal Disease Patients

 Program designed to improve clinical outcomes for Aetna members with kidney
                 failure while reducing overall cost of care

Business Wire

WALTHAM, Mass. & HARTFORD, Conn. -- June 10, 2014

Fresenius Medical Care (NYSE: FMS) and Aetna (NYSE: AET) announced today a
collaborative care model designed to improve the quality of care for Aetna’s
Medicare Advantage members who have end stage renal disease, while lowering
health care costs.

Fresenius Medical Care North America’s (FMCNA) nationally-recognized care
management program is accredited by the National Committee for Quality
Assurance, and creates a new approach for the overall delivery of care focused
squarely on the unique needs of dialysis patients. Through this collaboration,
Aetna nurse case managers will work closely with FMCNA staff on quality and
care management for Aetna Medicare Advantage members who are receiving care at
an FMCNA clinic. Aetna and FMCNA will work together to improve the health
outcomes of these patients by boosting adherence to best practices and
treatment plans.

“We are proud to collaborate with Aetna and deliver the resources and
customized therapies necessary to improve the lives of people living with end
stage renal disease,” said Ron Kuerbitz, Chief Executive Officer of Fresenius
Medical Care North America. “This collaboration embodies a truly integrated
approach to serving the full spectrum of health care needs for this vulnerable
population.”

“Aetna is committed to helping our Medicare members work with their doctors to
improve their quality of life by better managing the conditions contributing
to or resulting from chronic kidney disease,” said Robert Mirsky, M.D.,
Aetna’s chief medical officer for Medicare. “We value our collaboration with
Fresenius Medical Care and the complementary capabilities they can provide to
improve the care our members receive from them.”

This collaboration builds upon the relationship between Fresenius Medical Care
and Aetna, who continue to expand a joint program to identify Aetna Medicare
members with chronic kidney disease, and provide education, training and care
management designed to ease what can be a difficult transition to dialysis or
pre-transplant care.

About Fresenius Medical Care North America

Through its leading network of more than 2,150 dialysis facilities in North
America and vascular access centers, laboratory, pharmacy and affiliated
hospitals and nephrology practices, Fresenius Medical Care provides renal
services to hundreds of thousands of people throughout the United States,
Mexico and Canada. It is also the continent's top producer of dialysis
equipment, dialyzers and related disposable products and a major supplier of
renal pharmaceuticals. For more information about the company, visit
www.fmcna.com; for information about patient services, visit
www.ultracare-dialysis.com.

About Aetna

Aetna is one of the nation's leading diversified health care benefits
companies, serving an estimated 44 million people with information and
resources to help them make better informed decisions about their health care.
Aetna offers a broad range of traditional, voluntary and consumer-directed
health insurance products and related services, including medical, pharmacy,
dental, behavioral health, group life and disability plans, and medical
management capabilities, Medicaid health care management services, workers'
compensation administrative services and health information technology
products and services. Aetna's customers include employer groups, individuals,
college students, part-time and hourly workers, health plans, health care
providers, governmental units, government-sponsored plans, labor groups and
expatriates. For more information, see www.aetna.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20140610005179/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50882575&lang=en

Contact:

Media contacts:
Fresenius Medical Care
Jon Stone, 781-699-9704 (o)/781-392-4680 (cell)
Jonthan.d.stone@fmc-na.com
or
Aetna
Kendall Marcocci, 717-540-6746 (o)/717-645-9496
kmarcocci@cvty.com
 
Press spacebar to pause and continue. Press esc to stop.